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The development of endothelial cell precursors is essential for vasculogenesis. We screened for differentially
expressed transcripts in endothelial cell precursors in developing mouse embryoid bodies. We cloned a
complete cDNA encoding a protein that contains an amino-terminal signal peptide, five cysteine-rich domains,
a von Willebrand D domain, and a trypsin inhibitor domain. We termed this protein BMPER (bone morpho-
genetic protein [BMP]-binding endothelial cell precursor-derived regulator). BMPER is specifically expressed
in flk-1-positive cells and parallels the time course of flk-1 induction in these cells. In situ hybridization in
mouse embryos demonstrates dorsal midline staining and staining of the aorto-gonadal-mesonephric region,
which is known to host vascular precursor cells. BMPER is a secreted protein that directly interacts with
BMP2, BMP4, and BMP6 and antagonizes BMP4-dependent Smad5 activation. In Xenopus embryos, ventral
injection of BMPER mRNA results in axis duplication and downregulation of the expression of Xvent-1
(downstream target of Smad signaling). In an embryoid body differentiation assay, BMP4-dependent differ-
entiation of endothelial cells in embryoid bodies is also antagonized by BMPER. Taken together, our data
indicate that BMPER is a novel BMP-binding protein that is expressed by endothelial cell precursors, has
BMP-antagonizing activity, and may play a role in endothelial cell differentiation by modulating local BMP activity.
Vasculogenesis, the formation of blood vessels de novo from
precursor cells, is the first means by which the vascular system
forms during embryogenesis; many of the events in these early
stages of vascular development are recapitulated in adult vas-
cular outgrowth and disease. The first discernible event in the
vasculogenic process is the differentiation of endothelial cells
from mesoderm-derived precursors; failure of vascular growth
and developmental arrest occur in the absence of endothelial
cell differentiation (57). Although poorly understood, the early
cues that trigger endothelial cell differentiation from their im-
mediate progenitors affect many subsequent morphogenic and
organogenic events in the embryo.
During the earliest stages of mammalian development, en-
dothelial cells arise from precursors located both in the ex-
traembryonic compartment and within the embryo proper. Dif-
ferentiation of endothelial cells from precursors occurs in close
proximity to primitive hematopoeitic cells in structures called
blood islands, and it is widely accepted that a population of
bipotential cells in the early developing embryo can give rise to
both hematopoietic (32) and endothelial (71) cell lineages (and
possibly also some smooth muscle cell populations as well [20,
27; P. Carmeliet, Comment, Nature 408:43, 45, 2000]). These
cells are termed hemangioblasts and can be identified by the
presence of fetal liver kinase 1 (flk-1, also known as vascular
endothelial cell growth factor receptor 2) and other markers
(46). Persistent expression of flk-1 in these cells is associated
with differentiation along the endothelial cell lineage, whereas
loss of flk-1 expression characterizes differentiating hemato-
poietic progeny (70). During mouse embryonic development,
hemangioblasts are initially located in the aorto-gonadal-
mesonephric (AGM) region and in the yolk sac. Yolk sac-
derived hemangioblasts are the source of primitive hematopoi-
etic and endothelial cells that express some but not all markers
of mature endothelium and that form a primitive vasculature
(11, 12). Precursor cells within the AGM region are also fated
to give rise to hematopoietic and endothelial cell lineages (47).
The AGM region hosts hemangioblasts (54); it is a source of
the definitive hematopoietic system and contributes to the de-
finitive vasculature in the mouse embryo (40). The molecular
events that determine the generation and differentiation of
endothelial cell precursors are not well defined at present.
A number of signaling pathways downstream of endothelial
cell differentiation—notably, those activated by members of
the vascular endothelial cell growth factor (VEGF) and angio-
poietin family—have been implicated in vascular patterning
(22). In addition, positive and negative cell surface markers are
available for the characterization of embryonic endothelial
cells and their precursors; among them are flk-1 (which deco-
rates hemangioblasts and all endothelial cells) and PECAM
and VE-cadherin (which identify more mature endothelial
cells) (18). In contrast, upstream signaling molecules and tran-
scription factors that trigger mesodermal differentiation to-
ward the vascular endothelial cell lineage are less well under-
stood. Notably, recent studies have indicated a necessary role
for Indian hedgehog, a secreted ligand for the Patched recep-
* Corresponding author. Mailing address: Carolina Cardiovascular
Biology Center, University of North Carolina at Chapel Hill, 5.109C
Neurosciences Building, Chapel Hill, NC 27599-7126. Phone: (919)
843-6477. Fax: (919) 843-4585. E-mail: cpatters@med.unc.edu.
5664
tor, in blood island formation and endothelial cell precursor
specification (8, 19); however, the effects of Indian hedgehog
are not specific to the vasculature, and other signals must
surely cooperate with Indian hedgehog signaling to establish
the cues necessary to recruit vascular progenitors from their
mesodermal precursors.
Bone morphogenetic proteins (BMPs) represent another
family of signaling molecules that have been implicated, albeit
less directly, in hematopoietic and endothelial cell differenti-
ation. BMPs are members of the transforming growth factor 
(TGF-) superfamily of proteins, which consists of more than
30 members classified into several subgroups according to their
structural features. Signaling events mediated by these pro-
teins are tightly regulated and play crucial roles in embryonic
development. In Drosophila, Decapentaplegic (Dpp), the ho-
molog of vertebrate BMP2 and BMP4, and its specific antag-
onist, Short gastrulation (Sog), the homolog of vertebrate
Chordin (Chd), form a gradient that is necessary for dorsal-
ventral patterning of the embryo (21). In vertebrates, BMPs
were initially described by their ability to induce ectopic bone
and cartilage formation (64). However, BMP expression stud-
ies and loss-of-function mouse models have demonstrated a
broad range of activities of the different BMP family members
for various cell types. BMP signaling plays an essential role in
left-right asymmetry of the embryo, neurogenesis, mesoderm
patterning, and organogenesis (4). BMP2 or BMP4 is required
for the genesis of hematopoietic cell lineages in Xenopus (37,
66), and BMP4 cooperates with VEGF to specify lymphohe-
matopoietic cell development in mouse embryonic stem (ES)
cells (44). In addition, recent studies have implicated BMPs in
angiogenesis through a VEGF-dependent pathway (17).
Because so little is known about the early events in endo-
thelial cell specification, we have sought to identify their mo-
lecular determinants using an inductive approach. We have
used differentiating mouse ES cell-derived embryoid bodies
grown in attached cultures as a model of blood vessel devel-
opment; the anatomic and molecular events in embryonic en-
dothelial cell differentiation and blood vessel development are
faithfully recapitulated in this model (65, 67). In this report, we
describe the cloning and characterization of BMP-binding en-
dothelial cell precursor-derived regulator (BMPER), which
binds BMP4 and inhibits BMP-dependent developmental events
in several models, including Smad activation, mesoderm spec-
ification, and endothelial cell differentiation.
MATERIALS AND METHODS
Cells and reagents. Recombinant BMP4, BMP2, and BMP6 and the BMP4-
blocking antibody MAB757 were obtained from R&D Systems. The anti-BMP4
antibody used for Western blotting was obtained from Chemicon. Phycoerythrin
(PE)-conjugated anti-flk-1 antibody, fluorescein isothiocyanate-conjugated anti-
immunoglobulin G2 antibody, and purified anti-VE-cadherin antibody were pur-
chased from Becton Dickinson. Anti-Myc antibody 9E10 was obtained from
Santa Cruz Biotechnology.
ES cell culture. R1 mouse ES cells were grown on gelatinized tissue culture
plates with maintenance medium containing conditioned medium from human
5637 bladder carcinoma cells. Differentiation was initiated by harvesting ES cell
aggregates with dispase and culturing embryoid bodies in differentiation medium
(Dulbecco modified Eagle medium with 10% fetal calf serum and 50 M 2-mer-
captoethanol). Cells were initially grown in bacterial dishes to allow for the
formation of cystic embryoid bodies and were plated on tissue culture dishes
after 60 h for attachment. Attached embryoid bodies were grown under these
conditions for various times (5).
For BMP-dependent ES cell differentiation assays, R1 cells were grown under
conditions in which embryoid bodies survive but significant endothelial cell
differentiation occurs only after stimulation with growth factors (2, 43). After
commencement of differentiation, ES cells were grown in Dulbecco modified
Eagle medium supplemented with 10% knockout SR serum replacement
(Gibco) in bacterial dishes. After 48 h, cells were placed in six-well tissue culture
dishes with fresh medium and transfected with pSecTag2BMPER (see below) or
control plasmid by using the Fugene-6 method. Recombinant BMP4 or BMP4
preincubated with neutralizing antibody MAB757 was added to the dishes 24 h
after transfection. On day 5 of differentiation, the medium was replaced, and
BMP4 or BMP4-MAB757 was added again. On day 7, the embryoid bodies were
dissolved to single-cell suspensions by using trypsin and were analyzed by flow
cytometry.
Flow cytometry and cell sorting. ES cells were harvested with trypsin, washed
in phosphate-buffered saline (PBS)–0.1% bovine serum albumin (BSA), and
passed through a 40-m cell strainer. Cells were stained with the appropriate
antibody for 30 min, washed twice in PBS–0.1% BSA, and analyzed by using a
Becton Dickinson FACScan with Cytomation Summit software. For cell sorting
experiments, 107 cells were harvested in a similar manner, stained with PE-
conjugated anti-flk-1 antibody, washed, and sorted into the respective positive or
negative population by using a MoFlo instrument (Cytomation).
RNA preparation, Northern blotting, and PCR. Total RNA from cells in
culture or sorted cell suspensions was prepared by guanidinium isothiocyanate
extraction and centrifugation through cesium chloride (53).
The quality of the RNA was analyzed by agarose-formaldehyde gel electro-
phoresis, and quantification was performed spectrophotometrically. For North-
ern blotting, total RNA was separated by agarose-formaldehyde gel electro-
phoresis and transferred to a nitrocellulose membrane by capillary action (53).
The membrane was subjected to hybridization in hybridization buffer (Quickhyb;
Stratagene) with [32P]dCTP randomly labeled cDNA fragments and was exposed
to film. An adult mouse multiorgan blot was purchased from OriGene Technol-
ogies. Semiquantitative PCR was performed with the following primers: flk-1—
forward, 5-GGACTTCCTGACCTTGGAGC-3, and reverse, 5-GGGGTAGT
GTAGTCAGGAGC-3; glyceraldehyde-3-phosphate dehydrogenase (G3PDH)—
forward, 5-ACCACAGTCCATGCCATCAC-3, and reverse, 5-TCCACCACC
CTGTTGCTGTA-3; and BMPER—forward, 5-CCCGGCTGAGCCATGTG
TCC-3, and reverse, 5-CAGCTCCACAGACTTGGTCC-3.
cDNA library cloning and subtractive PCR. flk-1-positive and flk-1-negative
cDNA libraries were cloned by using a modification of Clontech SMART tech-
nology. Reverse transcription of total RNA from sorted ES cells was performed
with a modified oligo-dT primer containing an internal priming site, and an
asymmetrical primer site was attached at the 5 end of the reverse transcription
product. The cDNA libraries were amplified by PCR with the internal priming
site. An flk-1-enriched cDNA library was created by subtracting the flk-1-nega-
tive library from the flk-1-positive library by using subtractive PCR technology
(PCR-SELECT; Clontech). The resulting cDNA library was cloned into vector
pCR2.1 (Invitrogen), transformed into Escherichia coli, plated on Luria-Bertani–
ampicillin agar, and screened for inserts with blue-white color selection. White
colonies were grown in 96-well plates and used as a template for insert ampli-
fication by PCR. PCR products were spotted to create two identical nylon
membranes and were hybridized separately with [32P]dCTP randomly labeled
probes derived from the flk-1-positive and flk-1-negative sorted cDNA libraries.
Differentially expressed clones were sequenced. The full-length BMPER cDNA
fragment was cloned by 3 and 5 rapid amplification of cDNA ends with adult
mouse lung RNA as a template. For mammalian expression, the coding se-
quence, without the signal peptide, was cloned into pSecTag2 (Invitrogen) to
create pSecTag2BMPER, which contains a carboxy-terminal Myc tag for immu-
nodetection and the mouse kappa-chain immunoglobulin signal sequence at the
amino terminus for efficient secretion (35).
Western blotting, protein purification, and coimmunoprecipitation. COS-7
cells were transfected with pSecTag2BMPER by using the Fugene-6 method to
obtain Myc-tagged protein. At 24 h after transfection, the medium was changed
to OptiMEM-1, and cell supernatants were collected. To obtain cell lysates, cells
were washed with PBS and harvested in radioimmunoprecipitation buffer (150
mM NaCl, 50 mM Tris-HCl [pH 8.0], 1 mM EGTA, 1% Igepal, 0.5% deoxy-
cholate, 0.1% sodium dodecyl sulfate). Cell supernatants were concentrated with
Amicon Centriplus columns and analyzed by gel electrophoresis. Empty vector
transfections were used as controls. For BMP4 coimmunoprecipitation, samples
were immunoprecipitated with an anti-Myc–agarose conjugate for 2 h at room
temperature in immunoprecipitation (IP) binding buffer {150 mM NaCl, 1.5 mM
CaCl2, 1.5 mM MgCl2, 20 mM Tris-HCl (pH 7.5), 0.1% Triton X-100, 0.1%
deoxycholate, 0.1% 3-[(3-cholamidopropyl)-dimethylammonio]-1-propanesul-
fonate (CHAPS), 5% glycerol, 0.1% BSA}. Samples were washed three times in
IP binding buffer, pellets were resuspended in IP binding buffer, and BMP4 (5
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nM) and/or competing proteins (125 nM) were added for 2 h of incubation.
Samples were washed again three times in IP binding buffer without BSA and an
additional three times in radioimmunoprecipitation buffer for the competition
experiment and resuspended in 6 loading buffer (0.1 M Tris-HCl, 30% glycerol,
4% SDS, 0.05%, bromophenol blue, 1 M -mercaptoethanol), and Western
blotting was performed.
Reporter gene assay. A pGL2-based reporter construct containing an Smad5-
binding sequence (3GC2) upstream of the luciferase reporter gene was kindly
provided by M. Kato (26). 293T cells grown in six-well plates were transfected
with the reporter gene and pSecTag2BMPER or empty vector (control). BMP4
(final concentration, 0.5 nM) was added at 18 h after transfection. At 38 h after
transfection, cells were harvested in reporter lysis buffer (Promega), and lucif-
erase activity was analyzed by luminometry with a luciferase assay system (Pro-
mega). Each condition was analyzed with at least six independent samples, and
each sample was analyzed in triplicate.
In situ hybridization. Embryos were collected at different times from pregnant
CD-1 mice. After fixation in 4% paraformaldehyde, embryos were stained with
a digoxigenin-labeled antisense RNA probe or a respective sense control. Digoxi-
genin was detected with an alkaline phosphatase-conjugated antibody (Roche),
and the reaction was developed by adding nitroblue tetrazolium chloride–5-
bromo-4-chloro-3-indolylphosphate toluidine salt (Promega). For in situ analysis
of sections, whole embryos were fixed as described above, embedded in paraffin,
sectioned at 10 m, and placed on frosted slides before staining was performed
(7).
Xenopus laevis embryos and microinjections. X. laevis embryos were obtained
by in vitro fertilization (59) and dejellied by cysteine treatment (0.1 MBS
[8.8 mM NaCl, 0.1 mM KCl, 0.07 mM CaCl2, 0.1 mM MgSO4, 0.5 mM HEPES,
0.25 mM NaHCO3, pH 7.5] –2% L-cysteine hydrochloride [pH 8.1] for 2 min;
then 10 rinses with 0.1 MBS) about 1 h after cortical rotation. Embryos for
microinjection were transferred to 1 MBS containing 4% Ficoll type 400
(Sigma) (10). Full-length capped sense mRNA of BMPER and X. laevis BMP4
(pSP64) were synthesized by using T7 and SP6 RNA polymerases, respectively
(mMESSAGE mMACHINE; Ambion). For misexpression studies, 420 or 840 pg
of the BMPER transcript and 50 pg of the BMP4 transcript were injected into
the marginal zone of either two ventral or two dorsal cells at the four-cell stage
close to the first cleavage furrow, either alone or in combination, by using a
nitrogen pressure-driven system (Narishige IM-300). The embryos were trans-
ferred to 0.1 MBS 2 h after injection, allowed to develop to the desired stages,
and scored for secondary axis formation or the development of dorsoanterior
structures (dorsoanterior index [33]) at stage 14 or 32. The embryos were staged
as described by Nieuwkoop and Faber (45). The results (see Fig. 8A) are com-
bined totals from two independent experiments.
X. laevis animal cap assay and RT-PCR. For the animal cap assay, 840 pg of in
vitro-transcribed BMPER capped mRNA was injected into each of the four
animal blastomeres of eight-cell-stage embryos. Animal caps of injected and
noninjected embryos were explanted at the blastula stage (stage 8), cultured in
1 MBS with activin A (5 U/ml), and harvested at stage 10 (51). Total RNA
from Xenopus embryo caps was prepared by using a High Pure RNA kit (Roche).
Residual DNA was digested with DNase I, and RNA was quantified. For first-
strand synthesis, equal amounts of RNA were reverse transcribed with Super-
Script reverse transcriptase (RT) (Invitrogen) according to the manufacturer’s
instructions and with a random octamer primer mixture (Sigma). The PCR was
performed with Taq polymerase (Clontech Titanium) and with primers for X.
laevis transcripts for histone H4, Brachyury, Xvent-1, Chordin, and BMP4 (prim-
er sequences were from http://www.hhmi.ucla.edu/derobertis). Histone H4 was
included in the RT-PCR as a loading control.
Nucleotide sequence accession number. The BMPER full-length cDNA se-
quence has been deposited in GenBank under accession number AY263358.
RESULTS
We used an unbiased screen to identify genes potentially
involved in the earliest stages of endothelial cell differentia-
tion. This screen relied on the differentiation of ES cells, the
enrichment of endothelial cell precursor-specific cDNAs, and
molecular cloning (summarized in Fig. 1A). R1 mouse ES cells
were differentiated under conditions optimized for the devel-
opment of vascular precursor cells. Similar to previous reports
(32), we found with this model system that endothelial cell
progenitors identified by flk-1 expression were not detected in
appreciable quantities until 96 h after the initiation of differ-
entiation; also, their abundance as a percentage of total cells
peaked at 40% after 107 h (Fig. 1B), indicating rapid and
coordinated differentiation of endothelial cell precursors. At
the time of early—but significant—flk-1 expression (98 h), ES
cells were sorted into flk-1-positive and flk-1-negative fractions
(Fig. 1C); cDNA libraries were prepared from the respective
sorted cell populations. The population of flk-1-negative cells
could be separated from the population of flk-1-positive cells
with only minimal amounts of cross-contamination, confirming
successful cell sorting according to flk-1 status (Fig. 1D).
To further enrich for differentially expressed transcripts in
the flk-1-positive population, we performed a subtractive PCR
procedure that resulted in over 30-fold enrichment of flk-1
transcripts (Fig. 1E). Approximately 600 differentially ex-
pressed clones were analyzed, and among them we identified a
sequence for a previously undescribed cDNA (other tran-
scripts identified in this screen will be reported elsewhere). An
initial 1.2-kb RsaI-RsaI fragment of this sequence obtained
from the library was extended by successive rounds of 5 and 3
rapid amplification of cDNA ends to complete a cDNA of
3,314 bp (Fig. 2A). The cDNA contains a single open reading
frame that initiates at a consensus Kozak sequence and that
encodes a protein of 685 amino acids and with a predicted
molecular mass of 76.1 kDa. Analysis of the predicted protein
by comparison with the Pfam database (http://www.sanger.ac
.uk/Software/Pfam/) and the CBS signalP database (http://www
.cbs.dtu.dk/services/SignalP/) indicated the presence of a 39-
amino-acid signal peptide at the amino terminus, five tandem
cysteine-rich (CR) von Willebrand C-like domains, a single von
Willebrand D domain, and a sequence with homology to the
family of trypsin inhibitors at the carboxyl terminus. These
domains are all characteristic of secreted proteins; in particu-
lar, the presence of tandem CR domains is typical of BMP-
binding proteins, such as Chordin. The gene is located on
mouse chromosome 9A4 and contains 14 exons spanning 268.4
kb (Fig. 2B). A BLAST search indicated that the protein most
closely related to this sequence is encoded by the Drosophila
FIG. 1. Screening for differentially expressed cDNAs in endothelial cell precursors. (A) Outline of the screening strategy. (B) Time course of
flk-1 expression in embryoid body cultures. Hours are given to indicate the time after the initiation of differentiation. Single-cell solutions of
embryoid bodies were stained with PE-conjugated anti-flk-1 antibody. Subsequent studies were performed to coincide with the initial wave of flk-1
cell surface expression. (C) Separation of flk-1-positive endothelial cell precursors from flk-1-negative cells by sorting of a mixed single-cell solution
of embryoid body cultures at 98 h. Reanalysis demonstrated near homogeneity of the postsorting populations. (D) PCR (25 cycles) for flk-1 with
cloned cDNA libraries from flk-1-positive or -negative cells as a template. Highly efficient enrichment of flk-1 was seen. G3PDH was amplified as
a control. (E) PCR for flk-1 with the flk-1-positive cDNA library before (upper panel) or after (lower panel) subtraction of the flk-1-negative library
as a template. After subtraction, flk-1 was enriched approximately 32-fold (25).
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gene crossveinless-2 (GenBank accession number AF288223)
(14). Crossveinless-2 interacts genetically with the BMP signal-
ing pathway during fly wing development and contains both
CR and von Willebrand D domains but lacks the trypsin in-
hibitor domain. Based on our analysis described below, we
have called this mouse sequence BMPER.
RT-PCR confirmed strong preferential expression of this
cDNA in flk-1-positive cells derived from embryoid bodies;
expression was below the lower limits of detection in cells not
expressing flk-1 (Fig. 3A). The time course of BMPER expres-
sion during ES cell differentiation was examined by Northern
blot hybridization of a BMPER-specific probe to RNA ob-
tained at different times during ES cell differentiation (Fig.
3B). A single BMPER transcript of 3.5 kb was detected at low
levels in undifferentiated ES cells but was strongly downregu-
lated coincident with the initiation of differentiation. The high-
est levels of BMPER mRNA were detected at day 5 of embry-
oid body development, and expression slowly decreased through
day 9. Although flk-1 is not expressed in undifferentiated R1
ES cells, the pattern of flk-1 induction during differentiation
mirrored that of BMPER, consistent with the preferential ex-
pression of BMPER in flk-1-expressing cells (Fig. 3B).
The tissue expression of BMPER in adult mice was mea-
sured by Northern blot analysis. mRNA expression was highest
in the heart, lungs, and skin; lower expression was detected in
the brain (Fig. 3C). Other organs (including the thymus and
spleen, which are enriched in cells of hematopoietic origin) do
not express BMPER at detectable levels. The anatomical dis-
tribution of BMPER mRNA expression in embryos was
mapped by in situ hybridization. We observed a highly dynamic
pattern of expression of BMPER mRNA, which is common
during embryonic development. Analysis of mouse embryos at
day 9.5 showed characteristic dorsal midline staining with a
predominance in the most rostral region of the telencephalon
(Fig. 4A). A substantially weaker dorsal midline signal was
detected in the distal part of the tail (data not shown). Sections
of the same embryo showed a sharply restricted midline signal
in the cell layer adjacent to the telencephalic vesicle, corre-
sponding to the lamina reuniens (Fig. 4B). Additionally, at the
levels of somites 8 to 12, a migrating population of branchial
neural crest cells ventrolateral to the neural tube and dorsal to
Rathke’s pouch stained positive (Fig. 4C).
At day 10.5, the midline staining was no longer detectable in
whole-mount embryos. Instead, a BMPER signal could be
assigned to a symmetrical region ventrolateral to the dorsal
aorta by in situ hybridization of embryonic sections (Fig. 4E
and G). This anatomical region has been described elsewhere
as the AGM region (40, 41). A ring-shaped layer of cells
around the dorsal aorta, which are presumptive endothelial
cells, was also stained. Scattered adjacent mesenchymal or
migrating cells also expressed BMPER. Hybridization with
sense mRNA demonstrated the specificity of this expression
pattern (Fig. 4F and H).
BMPER RNA was also detected in yolk sacs. At day 9.5,
BMPER transcripts were expressed in a reticular staining pat-
tern consistent with staining of the developing yolk sac vascu-
lature (Fig. 5A) (48, 63). In yolk sac sections at day 10.5,
BMPER was detected in endothelial cells lining the inner layer
of the vascular wall (Fig. 5B). BMPER RNA was also detected
FIG. 3. BMPER mRNA expression in differentiating embryoid
bodies and adult tissue. (A) Expression of BMPER in flk-1-positive
and flk-1-negative cells sorted from differentiating embryoid bodies, as
determined by semiquantitative PCR. (B) Northern analysis with
cDNAs for BMPER, flk-1, and 18S rRNA (as an indicator of RNA
loading) to probe total RNA obtained from embryoid body (EB)
cultures on the indicated days of differentiation or from undifferenti-
ated ES cells (ES). After hybridization with BMPER, a single band of
3.5 kb was visible. (C) Northern analysis with a BMPER cDNA probe
of polyadenylated RNA from the indicated adult mouse tissues. Filters
were probed with -actin to visualize RNA loading. BMPER mRNA
expression was highest in the heart, lungs, skin, and brain.
FIG. 2. Cloning and analysis of the BMPER cDNA and gene. (A) Nucleotide (upper row) and deduced amino acid (lower row) sequences. The
open reading frame contains 2,055 bases coding for 685 amino acids. The predicted molecular mass is 76.1 kDa. The hydrophobic signal sequence,
CR domains 1 to 5, a partial von Willebrand D (vWD) domain, and a trypsin inhibitor (TI) domain are underlined. (B) Exon-intron organization
of the gene locus on mouse chromosome 9A4. (C) Structures of Crossveinless-2, Chordin, and Kielin in comparison to that of BMPER. TSP,
thrombospondin domain.
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in cell lines derived from yolk sac (C166) and intraembryonic
(MEC) endothelial cells (Fig. 5C). Taken together, these anal-
yses indicate that BMPER is expressed in primitive members
of the endothelial cell lineage in both the embryonic and the
extraembryonic compartments.
The significance of staining within the telencephalon at day
9.5 is uncertain, although BMP4 signaling has been linked to
midline pattern formation in this region by others (15). Like-
wise, BMPs control the fates of neural crest cells, such as those
expressing BMPER at day 9.5 (56). Most remarkably, the ex-
pression of BMPER in endothelial cell precursor-enriched re-
gions of the embryo is consistent with the preferential expres-
sion of BMPER in flk-1-positive cells in embryoid bodies. The
observation that BMPER is expressed at the right place and
time to affect endothelial cell differentiation provided the im-
petus for further analysis of the cellular and developmental
effects of BMPER.
Expression of BMPER in cultured mammalian cells (as a
carboxy-terminal Myc-tagged protein) resulted in the detection
of a protein with the appropriate molecular mass in cell lysates
(Fig. 6A). The full-length protein was also detected in cell
supernatants, as was a smaller protein, of about 42 kDa, which
likely represents a carboxy-terminal proteolytic fragment, as
has been described for other BMP-associated secreted pro-
teins, such as Chordin (36) and Chordin-like protein (43). The
presence of this fragment only in the secreted fraction suggests
that cleavage is dependent on an extracellular protease. Based
on the sequence similarity between BMPER and other BMP-
binding proteins, we tested the association of BMPER with
BMP4 and found that recombinant BMP4 could indeed be
efficiently and specifically immunoprecipitated by Myc-tagged
BMPER that was immunopurified after expression in COS-7
cells (Fig. 6B). We used competition assays to determine
whether the related BMPs BMP2 and BMP6, which overlap in
expression with BMPER along the dorsal midline (34), could
also bind BMPER (1); both of these proteins in a 25-fold
excess efficiently competed for binding between BMPER and
BMP4 (Fig. 6C), indicating that BMPER may also bind these
proteins. Bovine fibroblast growth factor in similar concentra-
tions did not compete for BMPER binding, demonstrating the
specificity of this assay.
Based on the association of BMPER with BMP4, we used
several complementary assays to determine the extent to which
BMPER modulates BMP activity. As a first test, we examined
the activation of a luciferase reporter gene under the control of
an Smad5-binding sequence that is known to be BMP4 respon-
sive. Stimulation of 293T cells with BMP4 resulted in approx-
imately 3.5-fold-increased luciferase activity (Fig. 7), consistent
with previous observations (26). The expression of BMPER by
itself had little effect on Smad5 reporter activity. However,
BMP-dependent activation of this reporter was almost com-
pletely inhibited by coexpression of BMPER. This effect oc-
curred in a dose-dependent fashion, and BMPER had no
activity for a luciferase reporter construct lacking the Smad5-
binding sequence, either with or without BMP4 (data not
shown). Because Smad5 binds to its DNA-binding site in re-
sponse to the activation of BMP4 signaling pathways, these
results provide evidence that BMPER has antagonizing effects
on BMP4 activity and its downstream Smad signaling path-
ways.
We next investigated the effects of BMPER on BMP signal-
ing in Xenopus based on the conservation of dorsal-ventral
patterning events during early stages of development. Past
studies showed that several secreted molecules expressed in
the Xenopus organizer (such as Noggin, Chordin, and Follista-
FIG. 5. BMPER expression in extraembryonic tissues and endothe-
lial cell lines. (A) Whole-mount in situ hybridization of a yolk sac at
day 9.5. Bar, 200 m. (B) In situ hybridization of a sectioned yolk sac
at day 10.5. Arrowheads indicate BMPER-positive cells. Bar, 70 m.
(C) Northern analysis of total RNA from cultured mouse intraembry-
onic endothelial cells (MEC) and cultured mouse yolk sac-derived
embryonic endothelial cells (C166) with a BMPER cDNA probe.
FIG. 4. Localization of BMPER mRNA in developing mouse embryos. (A) Whole-mount in situ hybridization of a mouse day 9.5 embryo with
a digoxigenin-labeled BMPER antisense cDNA probe. Note the midline staining in the rostral telencephalon (arrow). Bar, 500 m. (B) Transverse
section from the same embryo at the level indicated in the diagram at the lower left. Bar, 80 m. tv, telencephalic vesicle. (C) Magnification of
the frontal area from panel B. Bar, 20 m. (D) Transverse section of the embryo shown in panel A at the level indicated in the diagram. Bar, 80
m. nt, neural tube; rp, Rathke’s pouch; s, somite; nc, notochord. Cells that appear to be migrating ventrally toward the branchial arch and heart
region express BMPER. (E to H) In situ hybridization of sections from a day 10.5 mouse embryo. Arrows indicate the AGM region. (E and F)
Overview of BMPER staining (E) versus that of the sense control (F) at the level indicated in the diagram. Bar, 400 m. (G) Magnification of panel
E. Bar, 150 m. da, dorsal aorta. Note the staining of cells ventrolateral to the dorsal aorta and a ring-shaped layer of stained cells around the
dorsal aorta (arrowheads). (H) Magnification of panel F. Bar, 50 m. pg, primitive gut.
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tin) function to antagonize the effects of BMP signaling (25, 55,
60, 61, 69). When misexpressed, these factors either can lead to
the dorsalization of embryos or, when injected into the ventral
side of embryos, can cause the formation of a secondary axis.
To test whether BMPER can function as a BMP antagonist in
these assays, we injected BMPER mRNA into ventral or dorsal
blastomeres of four-cell-stage embryos and scored the samples
for the formation of a secondary axis. Consistent with the
FIG. 6. Mammalian expression of BMPER and BMP binding. (A) COS-7 cells were transiently transfected with vector pSecTag2BMPER,
which is tagged with a Myc epitope at the carboxyl terminus, or empty vector. Supernatant medium and whole-cell lysates were obtained and subjected
to Western blot analysis with an anti-Myc antibody. The arrow indicates full-length BMPER. (B) Myc-tagged BMPER purified from cell supernatants
was incubated with recombinant BMP4, as indicated, and reaction mixtures were immunoprecipitated (IP) with an anti-Myc antibody, followed by
Western blotting for BMP4 (lower panel). BMP4 was immunoprecipitated only in the presence of BMPER. In the third lane, BMP4 (10 ng) was
loaded directly as a control. The efficient immunoprecipitation of BMPER was confirmed by blotting for Myc (upper panel). n.s., nonspecific.
(C) Competition with BMP4 binding was used to determine the promiscuity of BMPER interactions with BMPs. Competition for coimmunopre-
cipitation of BMP4 with BMPER was tested in the presence of a 25-fold molar excess of BMP2, BMP6, or bovine fibroblast growth factor (bFGF).
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prediction that BMPER acts as a BMP antagonist, the injec-
tion of BMPER into ventral but not dorsal blastomeres leads
to the formation of a secondary axis (73 of 91 embryos had a
double axis after ventral injection of 840 pg of BMPER, com-
pared with 0 of 77 embryos after dorsal injection) (Fig.8A to
F). Moreover, the effects of BMPER are dose dependent, with
increasing extents of dorsalization and incidences of secondary
axis formation occurring concomitantly with increasing doses
of BMPER (Fig. 8A). Similar to previous descriptions of sec-
ondary axis formation in embryos injected ventrally with Chor-
din or Noggin, even the highest doses of BMPER rarely led to
the formation of more anterior structures, such as eyes or the
cement gland, in the newly formed axis (Fig. 8F) (55, 60, 61).
Secondary axis formation could be blocked almost completely
by coinjecting BMP4 along with BMPER mRNA into ventral
blastomeres (Fig. 9A). In a complementary set of experiments,
misexpression of BMP4 mRNA in dorsal blastomeres of early
cleavage stages leads to a loss of dorsoanterior structures and,
in more severe cases, to completely ventralized embryos (16,
28). However, coexpression of BMPER along with BMP4
mRNA in dorsal cells rescues the BMP4 phenotype by restor-
ing dorsoanterior structures (Fig. 9B). The dorsalization of
Xenopus embryos by BMPER is consistent with an antagonistic
effect on BMP signaling, as also indicated by our experiments
with the mammalian system.
To further characterize the effects of BMPER on BMP sig-
naling in Xenopus, we tested the ability of BMPER to block
BMP signaling in animal cap assays. In these experiments,
animal caps derived from noninjected or BMPER-injected em-
bryos were cultured in the presence of activin A, and meso-
derm induction and patterning in the early gastrula (stage 10)
were assessed by RT-PCR with a panel of mesoderm-specific
markers (Fig. 8G). After activin A stimulation, BMPER
blocked the expression of the ventral marker Xvent-1, the gene
for which was previously demonstrated to be a downstream
target of the BMP/Smad pathway (23). Interestingly, the
BMP4 transcript itself is also partially downregulated following
BMPER injection, a result which may be explained either by
inhibition of ventral mesoderm formation (16, 28) or by inhi-
bition of a positive BMP autoregulatory feedback loop, as
previously described (6). However, the effect on the ventral
mesoderm appears to be specific, since markers of the dorsal
mesoderm, such as Chordin, are unaffected. Interestingly we
do note a slight decrease in overall mesoderm formation, as
indicated by a minor reduction in Xbra expression (58). Taken
together, the results of our studies with Xenopus axis formation
and cap assays confirm that BMPER can function as a BMP
antagonist in a developmentally relevant context.
To examine BMPER function further in a model of mouse
embryonic development, ES cells were grown under conditions
that allow for cell survival but not for significant differentiation
without the addition of growth factors (2, 43). Under these
conditions, the stimulation of differentiating ES cells with
BMP4 results in the development of an endothelial cell sub-
population after 7 days of differentiation, as determined by
staining for the definitive endothelial cell marker VE-cadherin
(Fig. 10). Neutralization of BMP4 by a blocking antibody in-
hibited the differentiation of this endothelial cell subpopula-
tion. Comparable BMP4 inhibition was also observed in dif-
ferentiating ES cells that were transfected with BMPER and
subsequently stimulated with BMP4, although BMPER trans-
fection alone had no effect on endothelial cell differentiation in
the absence of stimulation. The quantitative analysis of three
independent experiments indicated a significant reduction of
VE-cadherin-positive cells in the MAB757- and BMP4-treated
embryoid bodies as well as in the BMPER-transfected and
BMP4-treated embryoid bodies compared to those treated
with BMP4 alone (Fig. 10F). These results further confirm the
BMP-inhibiting activity of BMPER and indicate that this ac-
tivity may serve to modulate the differentiation of endothelial
cells and their precursors in response to developmental cues,
as suggested by the developmental expression and cellular
function of this secreted protein.
DISCUSSION
Cloning of a novel BMP-binding protein. Although many of
the key signaling pathways in blood vessel formation are
known—including members of the VEGF and angiopoietin
family—the determinants of vascular cell differentiation at the
earliest stages remain poorly understood and logically require
input from multiple signaling pathways. In a model that reca-
pitulates key events in vasculogenesis under carefully con-
trolled conditions, we performed a screen for differentially
expressed genes as a means of identifying and understanding
the molecular events that determine the early stages of blood
vessel formation. By sorting for flk-1, a cell surface molecule
that is the first marker of the endothelial cell lineage expressed
during development, we defined a population of rapidly differ-
entiating endothelial cell precursors and separated them from
the surrounding cells by flow cytometry. cDNA libraries were
cloned from both populations and further enriched for the
flk-1-positive population by subtractive PCR. We show that the
isolation of endothelial cell precursors in this fashion is effi-
cient and that endothelial cell precursor-specific transcripts
can be identified. In this population, we discovered a differen-
FIG. 7. Effects of BMPER expression on BMP4 activity in mam-
malian cells. 293T cells were transiently transfected with an Smad5-
dependent luciferase reporter plasmid and pSecTag2BMPER or
control plasmid, as indicated. A plasmid expressing -galactosidase
was cotransfected to control for transfection efficiency. Recombinant
BMP4 or a control, as indicated, was added after 18 h and incubated
for an additional 20 h. Luciferase activity was normalized for transfec-
tion efficiency and expressed as a percentage of the activity in un-
treated cells (mean and standard deviation).
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FIG. 8. Effects of BMPER on dorsal-ventral axis development in X. laevis. (A) Summary of the effects of BMPER injection into Xenopus
blastomeres at the four-cell stage. n, number of embryos. Error bars indicate standard deviations. (B to D) Axis formation in Xenopus embryos
at stage 14. Bar, 750 m. (B) Control. (C) Dorsally injected. (D) Ventrally injected. Single asterisk, primary axis; double asterisk, secondary axis.
(E and F) Representative embryos at stage 32. Bar, 1 mm. (E) Control. (F) Ventrally injected. (G) Mesoderm marker gene expression in activin
A-treated animal caps, as analyzed by RT-PCR at stage 10. , injected; , not injected; H4, histone H4.
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tially expressed cDNA, called BMPER. Its expression pattern,
interactions with BMP family members, and function with re-
spect to BMP activity and endothelial cell differentiation pro-
vide a basis for understanding how the BMP signaling pathway
participates in vasculogenesis.
BMPs are a group of more than 30 proteins of the TGF-
superfamily of extracellular regulators. BMPs activate het-
erodimeric serine/threonine kinase receptors, which in turn
phosphorylate their intracellular substrates, the transcription
factors Smad1 and Smad5, to activate BMP-dependent gene
regulatory events (38). Molecules within the BMP signaling
pathway are critical for a number of developmental events,
including left-right asymmetry, mesoderm patterning, and the
development of several organs, such as the nervous system and
the heart (4). The classical BMP in Drosophila, Decapentaple-
gic, and its vertebrate homologs, BMP2 and BMP4, regulate
the patterning of the embryonic dorsal-ventral axis (21). The
activities of BMP family members are further regulated by
extracellular binding partners. Chordin and its Drosophila ho-
molog, Sog, are prototypical members of one family of binding
partners. Full-length Chordin binds to BMP2 and BMP4 and
inhibits their binding to BMP receptors, thus antagonizing
BMP activity (50). In Xenopus, Chordin is permissive for the
development of dorsally derived tissues, including somitic mus-
cle and neuroectoderm. Chordin may be cleaved and its BMP-
binding activity may be decreased (but not abolished) by the
metalloprotease Tolloid. The functional interaction of Chordin
and BMPs is further regulated by Twisted gastrulation, which
stabilizes the association of full-length (but not cleaved) Chor-
din with BMP (36). Twisted gastrulation may therefore serve
as an agonist or as an antagonist of BMP activity, depending on
local gradients of Chordin and Tolloid.
Chordin contains four conserved 70-amino-acid CR repeats
that comprise its BMP-binding activity. It is now recognized
that the presence of CR repeats defines a group of proteins
that bind to and, in general, antagonize BMPs, among these
being Procollagen IIA, Neuralin, and Kielin (13, 39, 73). On
the basis of the five CR repeats present in BMPER, we con-
sidered the possibility that it is also a BMP-binding protein.
Indeed, we found that BMPER efficiently bound BMP4 (Fig.
6B and C) and that BMPER could repress BMP-dependent
Smad5 transcriptional activation (Fig. 7). Additionally, BMPER
could rescue BMP4-ventralized Xenopus embryos (Fig. 9B). In
Xenopus animal caps, injection of BMPER mRNA completely
abolished the transcription of Xvent-1 (Fig. 8G), which is a
downstream transcriptional target of BMP4 signaling via
Smad5 activation (23). Interestingly BMP4 activity itself was
somewhat downregulated in this assay (although not to the
extent of Xvent-1), consistent with reports of BMP4 autoreg-
ulation (2, 6). In addition, BMPER resulted in axis duplication
activity when injected into early Xenopus embryos ventrally but
had no effect when injected into dorsal blastomeres. These
findings are in congruence with the consequences of injection
of Chordin into the same locations (55).
Coinjections of BMPER and BMP4 into ventral blastomeres
rescued the dorsalizing activity of BMPER, and coinjections
into dorsal bastomeres rescued the ventralizing effect of
BMP4, supporting the hypothesis that BMPER acts by antag-
onizing BMP4 (Fig. 9). Finally, using an established ES cell
assay (43), we show that BMPER inhibits BMP4-dependent
endothelial cell differentiation (Fig. 10E). It has been reported,
with a similar model of differentiating ES cells, that the ex-
pression of a dominant-negative BMP receptor blocks differ-
entiation into flk-1-positive lineages (2). The effects of BMPER
in our studies are similar, providing further support for the
notion that BMP signaling events are important in endothelial
cell differentiation, with BMPER acting as an endothelial cell
precursor-derived inhibitor of this process. We have demon-
strated, using multiple methods, that BMPER is a new mem-
ber of the group of CR repeat-containing BMP-binding part-
ners. Under the conditions observed here, it acts as a BMP
antagonist.
Structure of BMPER. In addition to five CR repeats,
BMPER also contains a von Willebrand D domain (Fig. 2C),
which in some situations functions as a multimerization mod-
FIG. 9. Coinjection of BMPER and BMP4. (A) Effects of coinjec-
tion of BMPER and BMP4 (50 pg) into both ventral blastomeres at the
four-cell stage versus injection of BMPER alone. Embryos were scored
for secondary axis formation at stage 14. Symbols: , single axis; ■ ,
secondary axis. (B) Effects of coinjection of BMPER (840 pg) and
BMP4 (50 pg) into both dorsal blastomeres versus injection of BMP4
alone. Embryos were scored for dorsoanterior structures at stage 32.
DAI, dorsoanterior index. Symbols: , BMP4, 25 embryos; ■ , BMP4
plus BMPER, 21 embryos.
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ule (3, 30, 31). Two additional CR repeat-containing proteins
also have von Willebrand D domains. Kielin (a Xenopus BMP
repressor) has 27 CR repeats and a carboxy-terminal von Wil-
lebrand D domain; Kielin has BMP-antagonizing activity, al-
though its ability to interact with BMPs has not been formally
demonstrated (39). Crossveinless-2 is a Drosophila protein that
contains five CR domains and a carboxy-terminal von Wille-
brand D domain but no trypsin inhibitor domain. The gene
encoding this protein was positionally cloned based on its req-
uisite role in wing cross vein development (14). Although the
biochemical function of Crossveinless-2 (in particular, whether
it directly interacts with BMPs) has not been reported, it does
interact with BMP activity genetically in Drosophila. In partic-
ular, Crossveinless-2 potentiates Decapentaplegic signaling in
the wing. This finding suggests that, unlike other reported CR
repeat-containing proteins that modulate BMP activity, Cross-
FIG. 10. Effects of BMPER on BMP-dependent differentiation of ES cells into endothelial cells. Embryoid bodies were incubated for 7 days
under serum-free conditions. Definitive endothelial cells were detected by flow cytometry with an anti-VE-cadherin rat immunoglobulin G2
antibody and the respective fluorescein isothiocyanate (FITC)-conjugated secondary antibody. (A and B) VE-cadherin-positive cells were rare in
the absence of BMP4 (A), and BMPER expression had a minimal effect under these conditions (B). (C and D) Expansion of the endothelial cell
population increased in the presence of recombinant BMP4 (1 nM) (C), but this effect was attenuated when recombinant BMP4 was preincubated
for 30 min at 37°C with a blocking antibody (MAB757) at a final concentration of 2 g/ml (D). (E) Similarly, the expression of BMPER inhibited
endothelial cell differentiation induced by BMP4. Results for panels A to E are representative of three independent experiments. (F) BMP4-
dependent endothelial cell differentiation in embryoid bodies, as determined on the basis of VE-cadherin-positive cells in treated cells. Error bars
indicate standard errors of the mean. An asterisk indicates a P value of 0.05 for a comparison with BMP4-treated cells.
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veinless-2 is an agonist rather than an antagonist of BMP
function.
The size and domain structure of BMPER and Crossvein-
less-2 are similar, and they share 30% identity and 44% simi-
larity at the amino acid level. It is possible that BMPER and
Crossveinless-2 are orthologs, although the biochemical effects
of BMPER presented in this report and the genetic functions
of Crossveinless-2 with respect to BMP activity are incongru-
ent. The possibility that these two proteins are structurally
similar yet have divergent functions cannot be excluded. It is
possible that the presence of the trypsin inhibitor domain in
BMPER confers functions different from those of Crossvein-
less-2. More complex models can also be developed, based on
the assumption that these proteins are indeed structural and
functional homologs. The precedent of Twisted gastrulation,
which has both pro- and anti-BMP activities depending on the
concentrations and activities of Chordin and Tolloid (36),
raises the possibility that antipodal functions may be a more
general property of BMP-binding proteins.
In this context, it is interesting that a second Crossveinless
phenotype exists in Drosophila; this phenotype is due to mu-
tation of twisted gastrulation-2, a second twisted gastrulation
gene that arose spontaneously in Drosophila (52). The similar
phenotypes suggest that Twisted gastrulation-2 and Crossvein-
less-2 together activate Decapentaplegic signaling in Drosoph-
ila. Whether the mammalian homolog of Twisted gastrulation
has a similar effect on BMPER remains to be determined (in
contrast to Drosophila, mammals contain only one twisted
gastrulation gene), but is an interesting possibility that would
reconcile these two studies. Such a model is not entirely spec-
ulative. In our studies, we noted that BMPER undergoes pro-
teolytic cleavage in the extracellular space (Fig. 6A) to yield a
carboxy-terminal fragment of approximately 42 kDa. (An ami-
no-terminal fragment may also be present but would not be
detectable in our assays because our protein was tagged at the
carboxyl terminus.) Because the effects of Twisted gastrulation
as an agonist or antagonist of BMPs depends in large part on
Tolloid-dependent cleavage of Chordin, it is tempting to spec-
ulate that cleavage of BMPER by a protease may ultimately
alter its function toward BMP4, perhaps through interactions
with Twisted gastrulation or a similar protein. Although this
model is attractive, we have not yet found evidence for such a
dual function, and in our diverse assays, BMPER consistently
behaves as a BMP antagonist.
BMPER and angioblast differentiation. The design of our
initial screen, to determine genes that are preferentially coex-
pressed with the flk-1 gene in differentiating ES cells, raises the
interesting possibility that BMPER has a role in angioblast
differentiation and/or vasculogenesis. With the exception of
ALK1 (49) and endoglin (24, 29, 62), which are coreceptors for
TGF- and BMP family members, a role for BMP family
members in vascular formation has not been extensively stud-
ied. However, it is interesting that the deletion of several pro-
teins involved in different steps of BMP signaling causes vas-
cular phenotypes in mice. For example, bmp4 mutants have
compromised blood and endothelial cell development result-
ing from defective blood island formation (68). Not surpris-
ingly, the phenotype that results from the deletion of BMP
receptor type I is very similar to the bmp4/ phenotype (42).
Most mouse embryos lacking bmp2 have, in addition to im-
paired mesoderm formation, defective heart development in
the embryos that survived gastrulation (72). Targeted mutation
of smad5, which encodes a transcription factor downstream of
BMP2 or BMP4, results in the disorganization of yolk sac
vasculature and heart development perturbation similar to that
seen in bmp2 mutants (9). The general conclusion of these
studies is that the BMP signaling pathway has a requisite role
in vascular development. However, to our knowledge, the spe-
cific expression of BMP-related proteins in the vascular com-
partment has not yet been described, and so it is as yet unclear
how BMPs mediate specific effects on vascular progenitors.
BMPER is expressed with marked specificity in flk-1-posi-
tive ES cells (Fig. 3A), which are generally considered to rep-
resent the earliest stage of the endothelial cell lineage in this
model and in mouse embryos, and the temporal expression of
BMPER closely mimics that of flk-1 (Fig. 3B). In mouse em-
bryos, BMPER is expressed in the AGM region, which is
enriched in cells of the vascular lineage, as well as in endothe-
lial cells that have been incorporated into the aorta. As an
inhibitor of BMP signaling (Fig. 7 to 9), BMPER would be
expected to antagonize endothelial cell differentiation, and
indeed this is the effect that we observed in differentiating ES
cells, which recapitulate most of the early developmental
events in vascular morphology (65, 67). Although the precise
role of BMPER in endothelial cell differentiation requires
further elucidation, our data indicate a model in which flk-1-
positive cells express BMPER in order to modulate local BMP
signaling. The expression of BMPER may inhibit the recruit-
ment of additional flk-1-positive cells to prevent vascular over-
growth, or BMPER may be secreted to encourage the differ-
entiation of other cell lineages that can arise from the same (or
spatially adjacent) precursor cells. This model would predict
that multipotential precursors may be primed to assume a
vascular lineage in response to stimulation by BMPs and that
the vascular expression of BMPER (and perhaps other pro-
teins that modify BMP responses) determines which cells re-
spond to local BMPs and which do not.
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ADDENDUM IN PROOF
While this paper was in review, a gene with an identical
sequence and similar embryonic expression pattern was re-
ported as the mouse homologue of Crossveinless-2 (C. Coffinier
et al., Gene Expression Profiles 2:189–194).
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